melarsoprol has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabrilove, JL; Jakubowski, A; König, A; Pandolfi, PP; Rivi, R; Warrell, RP; Wrazel, L | 1 |
| Hirschfeld, S; Soignet, SL; Tong, WP; Warrell, RP | 1 |
1 trial(s) available for melarsoprol and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia.
Topics: Adult; Aged; Area Under Curve; Female; Humans; Injections, Intravenous; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Melarsoprol; Middle Aged | 1999 |
1 other study(ies) available for melarsoprol and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Cell Division; Cell Line, Transformed; Cell Survival; DNA Damage; DNA Fragmentation; Drug Screening Assays, Antitumor; Herpesvirus 4, Human; Humans; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Melarsoprol; Oxides; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1997 |